by Jessica Emmerson | Apr 16, 2024 | Uncategorised
BSRBR-RA study blog BSRBR-RA Study website 🔗 We are thrilled to extend a warm invitation to join our sessions at the BSR’s Rheumatology conference. Held between 24th – 26th April 2024 at the ACC in Liverpool, this conference promises a wide variety of talks across all...
by Jessica Emmerson | Apr 10, 2024 | Biologic Therapy, Rheumatoid Arthritis
BSRBR-RA study blog BSRBR-RA Study website 🔗 What is Tyenne?  Tyenne is the first tocilizumab (interleukin-6) biosimilar that has recently been approved by the European Medicines Agency (EMA) for the treatment of moderate to severe rheumatoid arthritis in adults. It...
by Jessica Emmerson | Mar 13, 2024 | BSRBR-RA Team
BSRBR-RA study blog BSRBR-RA Study website 🔗 What is the BSRBR-RA? BSRBR-RA is the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. The primary aim of the study is to monitor the long term safety of biologics, biosimilars and other...
Recent Comments